Apocrine Metaplasia
Apocrine Metaplasia

•  This medium power view of several ducts shows the features of apocrine metaplasia.

•  The lining cells have abundant eosinophilic cytoplasm on the lumenal edge of the cell.

•  The nuclei are uniform and round.


(Image Contrib. by:UCHC)(Description by: Melinda Sanders, M.D.)
T78000M90703
Pathweb's Virtual Museum Home  eSynopsis of Pathology  eAtlas of Pathology
Simple Fibrocystic Change
Etiology

• Secondary to an irregular response by breast tissue to hormonal stimuli


Pathogenesis

• May be due to relative or absolute excess of estrogen, decrease in progesterone, or abnormal response to either hormone by breast tissue


Epidemiology

• 60-90% of breasts at autopsy

• Reproductive age women


Clinical

• About 10% of women have clinically evident disease

• May be associated with tenderness and irregular nodularity which varies during the menstrual cycle

• Microcalcifications may be demonstrable on mammogram

• May be associated with epithelial hyperplasia or sclerosing adenosis although these entities should be reported separately

• Cysts, fibrosis, adenosis, and apocrine metaplasia do not elevate risk for breast carcinoma


General Gross Description

• "Blue-dome" cysts which may be quite large

• Firm gray-white fibrous tissue


General Micro Description

• Cysts containing inspissated secretions which may calcify

• Cysts may also contain macrophages; lined by flattened epithelium

• Apocrine metaplasia with columnar epithelium containing small nuclei and brightly eosinophilic cytoplasm

• Adenosis, or increased numbers of acini in the lobule, may be present.

• If ducts are enlarged in acini the term blunt duct adenosis is used.


Reference

• Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005, p. 1127.


• Current literature from PubMed at National Library of Medicine


Synopsis by: Melinda Sanders M.D., UCHC
Apocrine Metaplasia
Etiology

• Secondary to an irregular response by breast tissue to hormonal stimuli


Pathogenesis

• May be due to relative or absolute excess of estrogen, decrease in progesterone, or abnormal response to either hormone by breast tissue


Epidemiology

• 60-90% of breasts at autopsy

• Reproductive age women


Clinical

• May be associated with tenderness and irregular nodularity which varies during the menstrual cycle

• Microcalcifications may be demonstrable on mammogram

•May be associated with epithelial hyperplasia or sclerosing adenosis

• Cysts and fibrosis do not elevate risk for breast carcinoma


General Gross Description

• "Blue-dome" cysts which may be quite large

• Firm gray-white fibrous tissue

General Micro Description

• Cysts containing inspissated secretions which may calcify

• Cysts may also contain macrophages; lined by flattened epithelium

• Apocrine metaplasia with columnar epithelium containing small nuclei and brightly eosinophilic cytoplasm


Reference

• Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th edition. Philadelphia, W.B. Saunders, 1994, pp. 1093-4.


• Current literature from PubMed at National Library of Medicine


Synopsis by: Melinda Sanders M.D., UCHC
Pathweb's Virtual Museum Home  eSynopsis of Pathology  eAtlas of Pathology